Bringing the fundamentals into focus…
Back to Prime Medicine, Inc.
How Prime Medicine, Inc. stacks up
PRME · against 1,216 other Healthcare companies
Growth
86/ 100
Near the top of its peers.
Ranked #166 of 1,217 · scores higher than 86% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 80–89, including PRME · Click a bar to see the companies
Why growth scores 86?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, which is stronger than most Healthcare peers.
- 3-year revenue growth is not reported, so it is left out of the score.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 91% of peers. Revenue growth: 55.3% vs peer median 6.1%
Metric by metric
Position: dot = PRME, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PRME | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 55.3% | 6.1% | 91% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | Not reported | 5.8% | — | — | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around PRME| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 166 | 336M USD | 86 | 43 | |
| 166 | 2.3B USD | 86 | 74 | |
| 166 | 56.0B USD | 86 | 39 | |
| 166 | 1.1B EUR (≈$1.2B) | 86 | 72 | |
| 166 | 825M USD | 86 | 24 | |
| 166 | 1.5B EUR (≈$1.6B) | 86 | 44 | |
| 166 | 14.4B USD | 86 | 71 | |
| 166 | 1.9B USD | 86 | 42 | |
| 178 | 3.4B CNY (≈$478M) | 85 | 77 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score